Moti Haim: Transforming AF Care in the Elderly
Moti Haim, Professor and Director of Cardiology at Soroka Medical Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in BMJ Journals, adding:
”Excited to share our new nationwide study, just published in BMJ Open!
We analyzed a decade of electronic health records (2010–2020) for 45,820 elderly patients (median age 83) with atrial fibrillation to look at real-world trends and clinical outcomes during the DOAC era.
Key findings:
Practice Shift: Initial OAC prescriptions grew from 31 percent in 2010 (all warfarin) to 66 percent in 2019 (mostly DOACs).
DOAC Benefits: DOAC use was associated with lower risks of ischemic stroke and gastrointestinal bleeding compared to non-users.
DOACs vs. Warfarin: DOACs outperformed warfarin across stroke, bleeding, and mortality outcomes.
Mortality Risk: Patients receiving no OAC therapy faced the highest mortality rates.
I am very proud of this work and want to congratulate and thank my brilliant co-authors. It has been a true privilege working with such a dedicated team.”
Title: Direct oral anticoagulants in elderly patients with atrial fibrillation: a decade-long nationwide retrospective cohort study
Authors: Hilmi Alnsasra, Gal Tsaban, Daniel Ostrovsky, Noa Livne, Blake Filderman, Yaakov Henkin, Zaza Iakobishvili, Yoav Arnson, Alon Eisen, Yiska Weisband, Jorge Schliamser, Moti Haim
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 22, 2026, 17:27Masudah Paleker: Suboptimal Warfarin Control in South Africa
-
Aug 22, 2026, 17:26Maxime Dely: Sickle Cell Disease – Behind Every Exchange, There Is a Donor
-
Aug 22, 2026, 17:05Mostafa Elshazly: Managing Anticoagulant-Related Bleeding in Clinical Practice
-
Aug 22, 2026, 17:01Cesarovic Nikola: FDA Data Reanalysis Raises Questions About Moderna’s mFLUSIVA Risk-Benefit Profile
-
Aug 22, 2026, 16:38Andreas Linkermann: Decoding the Chain Reaction of Ferroptotic Cell Death
-
Aug 22, 2026, 16:33Nicolas Hulscher: FDA Data Reanalysis Raises Alarms Over Moderna’s MFLUSIVA
-
Aug 22, 2026, 16:12Hussam Hammoud: A Slap Is Not “Just a Slap” When the Patient Has Hemophilia
-
Aug 22, 2026, 15:53Howard Smith: Publix’s GreenWise Organic Frozen Berries Have E. coli Contamination
-
Aug 22, 2026, 15:13Arthur Allen: Empowering Clinicians to Act